康泰医学：持股5%以上股东、部分董事及高管拟减持公司股份

Core Viewpoint - The major shareholders of Kangtai Medical (300869.SZ) plan to reduce their holdings through both centralized bidding and block trading methods, indicating potential changes in the company's ownership structure and market sentiment [1][2]. Group 1: Shareholder Reduction Plans - Major shareholder Wang Guili holds 47,126,226 shares (11.73% of total shares) and plans to reduce holdings by up to 4,000,000 shares (1.00%) through centralized bidding and up to 8,000,000 shares (1.99%) through block trading within three months after the announcement [1]. - Board member Yang Zhishan and director Gao Ruibin hold 2,157,138 shares (0.54%) and 1,230,902 shares (0.31%) respectively, with plans to reduce holdings by up to 539,000 shares (0.13%) and 300,000 shares (0.07%) through centralized bidding within the same timeframe [1]. Group 2: Additional Management Reductions - Senior management members Fu Chunyan, Kou Guozhi, Xu Yunlong, Liu Zhenhong, and Zheng Min hold shares of 2,476,772 (0.62%), 1,846,977 (0.46%), 891,452 (0.22%), 634,276 (0.16%), and 495,876 (0.12%) respectively, planning to reduce their holdings by up to 619,000 (0.15%), 460,000 (0.11%), 220,000 (0.05%), 158,000 (0.04%), and 120,000 (0.03%) shares through centralized bidding [2]. - The shareholders reducing their stakes through centralized bidding are limited to a maximum of 1% of the total shares over any continuous 90-day period, while those using block trading are limited to 2% [2].